Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Observational Study to Evaluate the Clinical Outcomes and Routine Management of Patients With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland

NCT03582098 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT03582098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03582098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Observational Study to Evaluate the Clinical Outcomes and Routine Management of Patients With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
September 12, 2018
Completion date
March 26, 2019
Enrollment
112 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukaemia